Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Team Medical LLC has 2 pending office actions in Biotechnology & Pharmaceuticals. These are distributed across 2 distinct examiners and a matching number of distinct art units, indicating that each matter is being reviewed by a different specialist. This distribution suggests that the company's current filings cover distinct technical aspects within the biotechnology field.
SHIN, DANA H is the busiest examiner, with 1 pending office action. The pending office actions are split among the distinct examiners, ensuring that the portfolio's outcomes are not dependent on a single person's perspective. For the practitioner, this decentralized structure requires managing multiple examiner relationships simultaneously. The use of multiple art units for only 2 pending office actions highlights a broad technical range for the company's current intellectual property efforts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHIN, DANA H | 1 | 26.9% | +26.9% |
| VYAS, KEYUR ANILKUMAR | 1 | 50.0% | +58.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18464129 | MATERIAL COMPOSITIONS AND METHODS OF USE IMPROVING RNA STABILITY | SHIN, DANA H | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18464129 | MATERIAL COMPOSITIONS AND METHODS OF USE IMPROVING RNA STABILITY | SHIN, DANA H | — |
| 17531297 | RNA STABILIZATION | VYAS, KEYUR ANILKUMAR | — |
| Art Unit | Apps |
|---|---|
| 1635 | 1 |
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18464129 | MATERIAL COMPOSITIONS AND METHODS OF USE IMPROVING RNA STABILITY | SHIN, DANA H | 1635 | §102§103§112DP | Non-Final OA | — | Pending | Sep 08, 2023 |
| 17531297 | RNA STABILIZATION | VYAS, KEYUR ANILKUMAR | 1637 | §102§112DP | Non-Final OA | — | Pending | Nov 19, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTeam Medical LLC has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Dana H Shin has the most, with 1 of Team Medical LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
